Patents by Inventor George R. Greene, Jr.
George R. Greene, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11890045Abstract: An embolic agent and a piezoelectric substance are mixed together. The mixture can be delivered to a tumor or other object by a non-invasive method. The embolic agent prevents movement of the piezoelectric substance from the target location. Subsequent impulses applied to the target location cause ablation of the surrounding area due to the piezoelectric effect of the particles, promoting highly accurate and precise ablation without the need for more invasive procedures.Type: GrantFiled: March 5, 2018Date of Patent: February 6, 2024Assignees: Regents of the University of Minnesota, MicroVention Inc.Inventors: Bharathi Jagadeesan, Sean Lester Moen, George R. Greene, Jr.
-
Publication number: 20230310056Abstract: An embolic agent and a piezoelectric substance are mixed together. The mixture can be delivered to a tumor or other object by a non-invasive method. The embolic agent prevents movement of the piezoelectric substance from the target location. Subsequent impulses applied to the target location cause ablation of the surrounding area due to the piezoelectric effect of the particles, promoting highly accurate and precise ablation without the need for more invasive procedures.Type: ApplicationFiled: June 9, 2023Publication date: October 5, 2023Inventors: Bharathi Jagadeesan, Sean Lester Moen, George R. Greene, JR.
-
Publication number: 20230008077Abstract: Devices, systems, and methods used to seal a treatment area to prevent embolic agents from migrating are described. The concept has particular benefit in allowing liquid embolic to be used with a variety of intravascular therapeutic applications, including for occluding aneurysms and arteriovenous malformations in the neurovasculature.Type: ApplicationFiled: September 15, 2022Publication date: January 12, 2023Applicant: MicroVention, Inc.Inventors: George R. Greene, Jr., Ivan Sepetka, Cathy Lei, Alejandro Berenstein, Monika Killer-Oberpfalzer, Heath Bowman
-
Publication number: 20220401104Abstract: An expansile member that may be used on a delivery device or may be used for occlusive purposes within the vasculature.Type: ApplicationFiled: August 24, 2022Publication date: December 22, 2022Applicant: MicroVention, Inc.Inventors: Hideo Morita, Greg Bak-Boychuk, Arnold Tuason, Matthew J. Fitz, George R. Greene, JR.
-
Patent number: 11484323Abstract: Devices, systems, and methods used to seal a treatment area to prevent embolic agents from migrating are described. The concept has particular benefit in allowing liquid embolic to be used with a variety of intravascular therapeutic applications, including for occluding aneurysms and arteriovenous malformations in the neurovasculature.Type: GrantFiled: December 20, 2019Date of Patent: November 1, 2022Assignee: MicroVention, Inc.Inventors: George R. Greene, Jr., Ivan Sepetka, Cathy Lei, Alejandro Berenstein, Monika Killer-Oberpfalzer, Heath Bowman
-
Patent number: 11426175Abstract: An expansile member that may be used on a delivery device or may be used for occlusive purposes within the vasculature.Type: GrantFiled: July 11, 2018Date of Patent: August 30, 2022Assignee: MicroVention, Inc.Inventors: Hideo Morita, Greg Bak-Boychuk, Arnold Tuason, Matthew J. Fitz, George R. Greene, Jr.
-
Patent number: 11389168Abstract: A temporary aortic occlusion device is disclosed, having an expandable locator portion and an expandable occlusion portion. The expandable locator portion assists a user in determining whether the distal end of the device has been advanced within a patient's aorta, and the occlusion portion is expanded to occlude the patient's aorta, preferably below the renal arteries.Type: GrantFiled: August 29, 2017Date of Patent: July 19, 2022Assignees: MicroVention, Inc., University of Virginia Patent Foundation, United States of America as Represented by the Secretary of the NavyInventors: George R. Greene, Jr., Ivan Sepetka, Cathy Lei, Rupal Nguyen, Matthew J. Bradley, Stephen T. Ahlers, Carl S. Goforth, James R. Stone
-
Patent number: 11389169Abstract: A temporary aortic occlusion device is disclosed, having an expandable locator portion and an expandable occlusion portion. The expandable locator portion assists a user in determining whether the distal end of the device has been advanced within a patient's aorta, and the occlusion portion is expanded to occlude the patient's aorta, preferably below the renal arteries.Type: GrantFiled: February 28, 2019Date of Patent: July 19, 2022Assignees: Microvention, Inc., University of Virginia Patent Foundation, United States of America as Represented by the Secretary of the NavyInventors: George R. Greene, Jr., Ivan Sepetka, Cathy Lei, Rupal Nguyen, Matthew J. Bradley, Stephen T. Ahlers, Carl W. Goforth, James R. Stone
-
Publication number: 20210137530Abstract: Devices, systems, and methods used to seal a treatment area to prevent embolic agents from migrating are described. The concept has particular benefit in allowing liquid embolic to be used with a variety of intravascular therapeutic applications, including for occluding aneurysms and arteriovenous malformations in the neurovasculature.Type: ApplicationFiled: December 17, 2020Publication date: May 13, 2021Applicant: MicroVention, Inc.Inventors: George R. Greene, JR., Ivan Sepetka, Cathy Lei, Alejandro Berenstein, Monika Killer-Oberpfalzer
-
Patent number: 10898203Abstract: Devices, systems, and methods used to seal a treatment area to prevent embolic agents from migrating are described. The concept has particular benefit in allowing liquid embolic to be used with a variety of intravascular therapeutic applications, including for occluding aneurysms and arteriovenous malformations in the neurovasculature.Type: GrantFiled: May 18, 2017Date of Patent: January 26, 2021Assignee: MicroVention, Inc.Inventors: George R. Greene, Jr., Ivan Sepetka, Cathy Lei, Alejandro Berenstein, Monika Killer-Oberpfalzer
-
Publication number: 20200138450Abstract: Devices, systems, and methods used to seal a treatment area to prevent embolic agents from migrating are described. The concept has particular benefit in allowing liquid embolic to be used with a variety of intravascular therapeutic applications, including for occluding aneurysms and arteriovenous malformations in the neurovasculature.Type: ApplicationFiled: December 20, 2019Publication date: May 7, 2020Applicant: MicroVention, Inc.Inventors: George R. Greene, JR., Ivan Sepetka, Cathy Lei, Alejandro Berenstein, Monika Killer-Oberpfalzer, Heath Bowman
-
Patent number: 10555738Abstract: Devices, systems, and methods used to seal a treatment area to prevent embolic agents from migrating are described. The concept has particular benefit in allowing liquid embolic to be used with a variety of intravascular therapeutic applications, including for occluding aneurysms and arteriovenous malformations in the neurovasculature.Type: GrantFiled: October 17, 2017Date of Patent: February 11, 2020Assignee: MicroVention, Inc.Inventors: George R. Greene, Jr., Ivan Sepetka, Cathy Lei, Alejandro Berenstein, Monika Killer-Oberpfalzer, Heath Bowman
-
Publication number: 20190192165Abstract: A temporary aortic occlusion device is disclosed, having an expandable locator portion and an expandable occlusion portion. The expandable locator portion assists a user in determining whether the distal end of the device has been advanced within a patient's aorta, and the occlusion portion is expanded to occlude the patient's aorta, preferably below the renal arteries.Type: ApplicationFiled: February 28, 2019Publication date: June 27, 2019Applicants: MicroVention, Inc., University of Virginia Patent Foundation, United States of America As Represented By The Secretary Of The NavyInventors: George R. Greene, JR., Ivan Sepetka, Cathy Lei, Rupal Nguyen, Matthew J. Bradley, Stephen T. Ahlers, Carl W. Goforth, James R. Stone
-
Publication number: 20180250058Abstract: An embolic agent and a piezoelectric substance are mixed together. The mixture can be delivered to a tumor or other object by a non-invasive method. The embolic agent prevents movement of the piezoelectric substance from the target location. Subsequent impulses applied to the target location cause ablation of the surrounding area due to the piezoelectric effect of the particles, promoting highly accurate and precise ablation without the need for more invasive procedures.Type: ApplicationFiled: March 5, 2018Publication date: September 6, 2018Inventors: Bharathi Jagadeesan, Sean Lester Moen, George R. Greene, JR.
-
Patent number: 10045786Abstract: An expansile member that may be used on a delivery device or may be used for occlusive purposes within the vasculature.Type: GrantFiled: November 19, 2014Date of Patent: August 14, 2018Assignee: MicroVention, Inc.Inventors: Hideo Morita, Greg Bak-Boychuk, Arnold Tuason, Matthew J. Fitz, George R. Greene, Jr.
-
Publication number: 20180070955Abstract: Devices, systems, and methods used to seal a treatment area to prevent embolic agents from migrating are described. The concept has particular benefit in allowing liquid embolic to be used with a variety of intravascular therapeutic applications, including for occluding aneurysms and arteriovenous malformations in the neurovasculature.Type: ApplicationFiled: October 17, 2017Publication date: March 15, 2018Applicant: MicroVention, Inc.Inventors: George R. Greene, JR., Ivan Sepetka, Cathy Lei, Alejandro Berenstein, Monika Killer-Oberpfalzer, Heath Bowman
-
Publication number: 20180055515Abstract: A temporary aortic occlusion device is disclosed, having an expandable locator portion and an expandable occlusion portion. The expandable locator portion assists a user in determining whether the distal end of the device has been advanced within a patient's aorta, and the occlusion portion is expanded to occlude the patient's aorta, preferably below the renal arteries.Type: ApplicationFiled: August 29, 2017Publication date: March 1, 2018Applicant: MicroVention, Inc.Inventors: George R. Greene, JR., Ivan Sepetka, Cathy Lei, Rupal Nguyen
-
Publication number: 20170367713Abstract: Devices, systems, and methods used to seal a treatment area to prevent embolic agents from migrating are described. The concept has particular benefit in allowing liquid embolic to be used with a variety of intravascular therapeutic applications, including for occluding aneurysms and arteriovenous malformations in the neurovasculature.Type: ApplicationFiled: May 18, 2017Publication date: December 28, 2017Applicant: MicroVention, Inc.Inventors: George R. Greene, JR., Ivan Sepetka, Cathy Lei, Alejandro Berenstein, Monika Killer-Oberpfalzer
-
Publication number: 20150174381Abstract: An expansile member is described. The expansile member may be used on a delivery device or may be used for occlusive purposes within the vasculature.Type: ApplicationFiled: November 19, 2014Publication date: June 25, 2015Inventors: Hideo Morita, Greg Bak-Boychuk, Arnold Tuason, Matthew J. Fitz, George R. Greene, JR.
-
Patent number: 9034005Abstract: A vascular implant formed of a compressible foam material has a compressed configuration from which it is expansible into a configuration substantially conforming to the shape and size of a vascular site to be embolized. Preferably, the implant is formed of a hydrophilic, macroporous foam material, having an initial configuration of a scaled-down model of the vascular site, from which it is compressible into the compressed configuration. The implant is made by scanning the vascular site to create a digitized scan data set; using the scan data set to create a three-dimensional digitized virtual model of the vascular site; using the virtual model to create a scaled-down physical mold of the vascular site; and using the mold to create a vascular implant in the form of a scaled-down model of the vascular site. To embolize a vascular site, the implant is compressed and passed through a microcatheter, the distal end of which has been passed into a vascular site.Type: GrantFiled: September 8, 2010Date of Patent: May 19, 2015Assignee: MicroVention, Inc.Inventors: George R. Greene, Jr., Robert F. Rosenbluth, Brian J. Cox